Wenmiao Wang
-
- Cancer Genomics and Diagnostics 5
- Breast Cancer Treatment Studies 4
-
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 3
-
- Genetic factors in colorectal cancer 3
-
- Lung Cancer Treatments and Mutations 3
-
- Advanced biosensing and bioanalysis techniques 3
- RNA modifications and cancer 3
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesEgypt
In The Last Decade
Wenmiao Wang
28 papers receiving 323 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 113
- Oncology 122
- Pathology and Forensic Medicine 56
- Pulmonary and Respiratory Medicine 62
- Molecular Biology 119
Countries citing papers authored by Wenmiao Wang
This map shows the geographic impact of Wenmiao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenmiao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenmiao Wang more than expected).
Fields of papers citing papers by Wenmiao Wang
This network shows the impact of papers produced by Wenmiao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenmiao Wang. The network helps show where Wenmiao Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenmiao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 28 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 15 | |
| 16 | 2020 | 25 | |
| 17 | 2019 | 21 | |
| 18 | 2018 | 6 | |
| 19 | 2015 | 12 | |
| 20 | 2015 | 15 |
About Wenmiao Wang
Wenmiao Wang is a scholar working on Cancer Research, Oncology and Endocrine and Autonomic Systems, having authored 30 papers that have together received 328 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Genetic factors in colorectal cancer (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (113 citations), Oncology (122 citations) and Pathology and Forensic Medicine (56 citations). Wenmiao Wang has collaborated with scholars based in China, United States and Egypt. Frequent co-authors include Chunyi Tong, Bin Liu, Jialong Fan, Pin Zhang, Fei Ma, Binghe Xu, Jiahai Shi, Peng Yuan, Jiayu Wang and Qing Li. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.